About the journal
Biomedicine & Pharmacotherapy is an open-access journal published by Elsevier BV in France. It is listed in MEDLINE and PUBMED according to the sources read. Declared publication charge: 2,660 USD. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Elsevier BV
- ISSN
- 1950-6007 · 0753-3322
- Country
- France
- Access
- Open access
- Declared publication charge
- 2,660 USD
- Declared peer-review model
- peer_review
Index listings
- MEDLINE · 1982-01-01
- PUBMED · 2007-06-29
- Indexing
- MEDLINE · PUBMED
- APC
- 2,660 USD
- Declared review time (DOAJ)
- —
- Actual review time (measured)
- 76 days received→accepted — computed from PubMed (n=91)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
20582
Last recorded publication year
2026
h-index
221
i10-index
13267
From OpenAlex open data (CC0).
Editorial & policy3
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Open references deposited at Crossref
- 87%
- ORCID iDs in current deposits
- 62%
- Deposits licence metadata at Crossref
- ✓
Identity & continuity3
- Alternate titles
- Biomédecine & pharmacothérapieBiomedicine and pharmacotherapy
- Source type
- journal
- NLM unique ID (PubMed)
- 8213295
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Cancer-related molecular mechanisms research
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- MicroRNA in disease regulation
- Circular RNAs in diseases
- Circular RNAs in diseases
- RNA modifications and cancer
- RNA modifications and cancer
Show all subjects (50)
- Autophagy in Disease and Therapy
- Autophagy in Disease and Therapy
- Liver Disease Diagnosis and Treatment
- Liver Disease Diagnosis and Treatment
- Cancer, Hypoxia, and Metabolism
- Cancer, Hypoxia, and Metabolism
- Genomics, phytochemicals, and oxidative stress
- Genomics, phytochemicals, and oxidative stress
- Pharmacological Effects of Natural Compounds
- Pharmacological Effects of Natural Compounds
- Natural Antidiabetic Agents Studies
- Natural Antidiabetic Agents Studies
- Natural product bioactivities and synthesis
- Natural product bioactivities and synthesis
- Neuroinflammation and Neurodegeneration Mechanisms
- Neuroinflammation and Neurodegeneration Mechanisms
- Gut microbiota and health
- Gut microbiota and health
- Immune Cell Function and Interaction
- Immune Cell Function and Interaction
- RNA Interference and Gene Delivery
- RNA Interference and Gene Delivery
- Immune cells in cancer
- Immune cells in cancer
- Drug Transport and Resistance Mechanisms
- Drug Transport and Resistance Mechanisms
- Immunotherapy and Immune Responses
- Nanoparticle-Based Drug Delivery
- Immunotherapy and Immune Responses
- Epigenetics and DNA Methylation
- Nanoparticle-Based Drug Delivery
- Epigenetics and DNA Methylation
- Drug-Induced Hepatotoxicity and Protection
- Drug-Induced Hepatotoxicity and Protection
- Tryptophan and brain disorders
- Tryptophan and brain disorders
- Phytochemicals and Antioxidant Activities
- Phytochemicals and Antioxidant Activities
- Traditional Chinese Medicine Analysis
- Immune Response and Inflammation
- Traditional Chinese Medicine Analysis
- Immune Response and Inflammation
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ